Sandra Gurrola
Vermögen: 40 $ am 30.06.2026
Vermögen: 40 $ am 30.06.2026
Sandra Gurrola worked as Senior Manager-Financial Reporting at Metabasis Therapeutics, Inc. from 2007 to 2009.
From 2009 to 2021, served as Secretary & Senior Vice President-Finance at NTN Buzztime, Inc. In 2021, held the position of Senior Vice President at eGames.com Holdings LLC.
From 2022 to 2023, worked as Principal Accounting Officer & VP-Finance at Ernexa Therapeutics, Inc. Completed undergraduate education at San Diego State University in 1991.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 07.05.2026 | 6 ( 0 % ) | 40 $ | 30.06.2026 |
| Unternehmen | Position | Ende |
|---|---|---|
| ERNEXA THERAPEUTICS INC. | Finanzdirektor/CFO | 03.07.2026 |
eGames.com Holdings LLC
eGames.com Holdings LLC Packaged SoftwareTechnology Services Operates as a game publishing business | Finanzdirektor/CFO | 01.06.2021 |
| NTN BUZZTIME, INC. | Finanzdirektor/CFO | 01.03.2021 |
Metabasis Therapeutics, Inc.
Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
NTN Buzztime, Inc.
NTN Buzztime, Inc. Packaged SoftwareTechnology Services Develops and distributes TV games for restaurants and sports bars | Technology Services |
Metabasis Therapeutics, Inc.
Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs | Health Technology |
San Diego State University
San Diego State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
eGames.com Holdings LLC
eGames.com Holdings LLC Packaged SoftwareTechnology Services Operates as a game publishing business | Technology Services |
Eterna Therapeutics, Inc.
Eterna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops cytokine-based drugs for the treatment of cancer | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen